Clinical Trial: Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: A Spanish Multicenter, Cross-sectional, Observational Study to Evaluate the Effectiveness of Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects in Daily Clini

Brief Summary: The purpose of this study is to evaluate the effectiveness in IGF-1 control of lanreotide Autogel (ATG) 120 mg at extended dosing intervals (EDIs) (>4 weeks) in subjects with acromegaly in daily clinical practice.